Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 1734-1741

  Madeira, Miguel ^a   Neto, Leonardo Vieira ^a   De Paula Paranhos Neto, Francisco ^a   Lima, Inayá Corrêa Barbosa ^a   De Mendonça, Laura Maria Carvalho ^a   Gadelha, Mônica Roberto ^a   De Farias, Maria Lucia Fleiuss ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE; THYROID HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE STRUCTURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL BONE; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GONAD FUNCTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; IMAGE ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRABECULAR BONE;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876259206     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4073     Document Type: Article

References (38)

1. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008;29(5):535-559.
2. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary. 1999;2:29-41.
3. Ezzat S, Melmed S, Endres D, Exre DR, Singer FR. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab. 1993;76:1452-1457.
4. Giustina A, Casanueva FF, Cavagnini F, et al; Pituitary Society and the European Neuroendocrine Association Diagnosis and treatment of acromegaly complications. J Endocrinol Invest. 2003;26:1242-1247.
5. Kaji H, Sugimoto T, Nakaoka D, et al. Bone metabolism and body composition in Japanese patients with active acromegaly. Clin Endocrinol (Oxf). 2001;55:175-181.
6. Ueland T, Ebbesen EN, Thomsen JS, et al. Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest. 2002;32:122-128.
7. Bolanowski M, Daroszewski J, Medras M, Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab. 2006;24:72-78.
8. Kayath MJ, Vieira JG. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporosis Int. 1997;7:226-230.
9. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf). 1998;48:59-65.
10. Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P. In acromegaly, increased bone mineral density is determined by GH excess, gonadal function and gender. Neuro Endocrinol Lett. 2007; 28:621-628.
11. Madeira M, Neto LV, Torres CH, de Mendonça LM, Gadelha MR, de Farias ML Vertebral fracture assessment in acromegaly [published online August 13, 2012]. J Clin Densitom. doi: 10.1016/j.jocd.2012.06.002.
12. Mazzioti G, Gola M, Bianchi A, et al. Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine. 2011; 40(1):102-108.
13. Wassenaar MJ, Biermasz NR, Hamdy NA, et al. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol. 2011; 164(4):475-483.
14. Delmas PD, Seeman E. Changesinbone mineral densityexplain little of the reduction in vertebral or nonvertebral fracture risk with antiresorptive therapy. Bone. 2004;34:599-604.
15. Cohen A, Dempster DW, Müller R, et al. Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int. 2010;21(2):263-273.
16. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90(12):6508-6515.
17. Vico L, Zouch M, Amirouche A, et al. High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res. 2008;23(11): 1741-1750.
18. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res. 2007; 22(3):425-433.
19. Dalzell N, Kaptoge S, Morris N, et al. Bone micro-architecture and determinants of strength in the radius and tibia: age-related changes in a population-based study of normal adults measured with highresolution pQCT. Osteoporos Int. 2009;20(10):1683-1694.
20. Nicks KM, Amin S, Atkinson EJ, Riggs BL, Melton LJ 3rd, Khosla S. Relationship of age to bone microstructure independent of areal bone mineral density. J Bone Miner Res. 2012;27(3):637-644.
21. Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imagingofcortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(11):5045-5055.
22. Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK. Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an invivo HR-pQCT study. J Bone Miner Res. 2010;25(4):882-890.
23. Giustina A, Chanson P, Bronstein MD, et al; Acromegaly Consensus Group. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95(7):3141-3148.
24. Madeira M, Neto LV, Moreira RO, de Mendonça LM, Gadelha MR, Farias ML. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Osteoporos Int. 2010;21:2019-2025.
25. Laib A, Hauselmann HJ, Ruegsegger P. In vivo high resolution 3DQCT of the human forearm. Technol Health Care. 1998;6:329-337.
26. Manske SL, Macdonald HM, Nishiyama KK, Boyd SK, McKay HA. Clinical tools to evaluate bone strength. Clin Rev Bone Miner Metab. 2010;8:122-134.
27. Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res. 1997;12:683-690.
28. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102-152.
29. Kreze A, Kreze-Spirova E, Mikulecky M. Risk factors for glucose intolerance inactive acromegaly. Braz JMed Biol Res. 2001;34(11): 1429-1433.
30. Tuominen JT, Impivaara O, Puukka P, Rönnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care. 1999;22:1196-1200.
31. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res. 2009; 24:702-709.
32. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos Int. 2007;18:427-444.
33. Melton LJ 3rd, Riggs BL, Leibson CL, et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab. 2008;93: 4804-4809.
34. Battista C, Chiodini I, Muscarella S, et al. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin Endocrinol (Oxf). 2009;70:378-382.
35. Ho PJ, Fig LM, Barkan AL, Shapiro B. Bone mineral density of the axial skeleton in acromegaly. J Nucl Med. 1992;33:1608-1612.
36. Kotzmann H, Bernecker P, Hubsch P, et al. Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res. 1993;8:459-465.
37. Canalis E, McCarthy TL, Centrella M. The role of growth factors in skeletal remodelling. Endocrinol Metab Clin North Am. 1989;18: 903-918.
38. Hyldstrup L, Conway GS, Racz K, et al. Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency. Osteoporos Int. 2012;23(8):2219-2226.